Trial
NCT01267643
Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The Cleveland Clinic
Collaborators
Astellas Pharma US, Inc.
Condition
Aplastic Anemia
Intervention
Alefacept
Why stopped
Study drug not available at this time
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-26